Thales Reinforces Its eSIM Management Leadership With Google Cloud Certified and Energy Efficient Services
1.3.2023 10:00:00 EET | Business Wire | Press release
Thales, the world leader in eSIM management, supports the growth of eSIM-enabled consumer and industrial devices with Google Cloud expertise. Thales' pioneering Cloud solution combines its own security assets with Google's cloud presence in 200 countries to provide enhanced security, flexibility, and service availability to MNOs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230228005040/en/
Thales, a global leader in eSIM management. @Thales
Remote eSIM activation, anytime and anywhere
By 2025, the number of eSIM connections is estimated to reach close to 9 billion1. Fuelled by 5G, the growth in connections is the result of increased connectivity of consumer products such as smartphones, tablets and wearables, and numerous industrial devices. With Thales’ eSIM management platform hosted on Google Cloud completed with Thales digital onboarding solutions, MNOs can offer their subscribers the speed, convenience and efficiency of activating subscriptions remotely. Today, Thales is able to meet high demands from hundreds of customers worldwide, including Telefonica, one of the world's largest telco operators and mobile network providers.
The perfect response to MNOs digital transformation and exponential IoT growth
With easy and secure access to Thales services hosted on Google Cloud, mobile operators can respond immediately to surging demand for eSIM activation and offer their subscribers a full digital experience. Such solutions also provide greater scalability as well as resources mutualisation, enabling mobile operators efficiently and rapidly deploy new services. In terms of security, Thales keeps full control, by designing highly secure end-to-end hardware and software, as well as by storing and managing the secret codes in its secure vaults (secret codes are keys used by devices for eSIM activation to securely access mobile networks). This underpins world-class data privacy, sovereign cloud approach and rigorous defence against cyberattacks.
Certified and sustainable
The eSIM usage has become mission-critical to enable a sustainable access to connectivity for the expanding consumer and industrial IoT. Thales’ integration of global GSMA-certified solution protects MNOs against interruptions in any part of the world. MNOs therefore benefit from outstanding disaster recovery, business continuity and improved quality of services.
Google Cloud’s is today one of the most energy efficient clouds2 in the industry and aims to operate entirely on carbon free energy 24/7 and everywhere in the world by 2030.
“ We have been trustfully partnering with Thales for years to address new connectivity challenges and MNO needs with cloud technology. This future-proof solution provides the market with the required flexibility, security, and resilience to meet consumer’s ‘anytime anywhere’ wish, while also addressing new technological requirements. Adding to Google Cloud services, the security aspect brought by Thales and its remote eSIM management leadership, brings relevance and support to MNOs eSIM strategy.” said Amol Phadke, General manager, Global Telecom Industry at Google Cloud
“There is an increasing consumers’ adoption of eSIM enabled phones, wearables and tablets while MNOs are ramping up for the 5G and IoT revolutions. Two years after the announcement of our partnership with Google Cloud, Thales’ pioneering Cloud eSIM solution has reached its full maturity. Our customers can trust us to support them in their eSIM strategy, meeting data privacy regulations as well as protecting them against the most sophisticated cyber threats” said Eva Rudin, VP Mobile Connectivity Solutions at Thales.
1
Counterpoint, eSIM Ecosystem CORE Analysis, May 2022
2
On average, a Google data center is twice as energy efficient as a typical enterprise data center.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations — connectivity, big data, artificial intelligence, cybersecurity and quantum computing — to build a future we can all trust, which is vital to the development of our societies.
The company provides solutions, services and products that help its customers —businesses, organisations and states — in the defence, aeronautics, space, transportation and digital identity and security markets to fulfil their critical missions, by placing humans at the heart of the decision-making process.
Thales has 81,000 employees in 68 countries. In 2021, the Group generated sales of €16.2 billion
PLEASE VISIT
Thales Group
Digital Identity & Security
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228005040/en/
Contact information
Thales, Media Relations
Digital Identity and Security
Vanessa Viala
+33 (0)6 07 34 00 34
vanessa.viala@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom